Results 11 to 20 of about 12,501 (219)

CONTRACEPCION DE EMERGENCIA: EFECTO POSTFERTILIZACION DEL LEVONORGESTREL

Revista Chilena de Obstetricia y Ginecología, 2003
Para las paciente y médicos que creen que la persona humana comienza su existencia con la fertilización, los métodos de planificación familiar que actúan interrumpiendo el desarrollo embrionario en sus primeras etapas no son éticamente aceptables.
Maritza Busquets C.
doaj   +2 more sources

Evaluation of Levonorgestrel Subdermal Implant as Long Term Reversible Contraceptive

Journal of Rawalpindi Medical College, 2018
Background: To study the reasons of acceptability, efficacy,short term and long term side effects of Levonorgestrel Subdermal implant as long term reversible contraceptive.
Taqdees Iftikhar, Jehan Ara, Humaira Arshad, Nadra Sultana   +3 more
doaj   +2 more sources

Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: An economic evaluation alongside a randomised controlled trial [PDF]

, 2014
Objective: To undertake an economic evaluation alongside the largest randomised controlled trial comparing Levonorgestrel-releasing intrauterine device ('LNG-IUS') and usual medical treatment for women with menorrhagia in primary care; and compare the ...
Lee Middleton, Kai, J, Middleton, Lee; id_orcid, Kai, Joe, Daniels Jane, Middleton, Lee, Frew, Emma, Middleton Lee, Tracy Elizabeth Roberts, Pelham Barton, Janesh Kumar Gupta, Frew Emma, Sanghera Sabina, Laura Gennard, Gennard, Laura, Jane Daniels, Emma Frew, Barton, Pelham, Barton, P, Daniels, J, Sanghera, S, Sabina Sanghera, Kai Joe, Gennard, L, Joe Kai, Middleton, L, Roberts, Tracy Elizabeth, Roberts Tracy Elizabeth, Barton Pelham, Frew, E, Gupta, Janesh Kumar, Gupta, Janesh, Roberts, TE, Sanghera, Sabina, Gupta Janesh Kumar, Frew, Emma; id_orcid, Daniels, Jane, Gupta, JK, Gennard Laura   +38 more
core   +1 more source

Non-contraceptive applications of the levonorgestrel intrauterine system [PDF]

, 2010
Maria Isabel Rodriguez, Philip D DarneyDepartment of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital and Bixby Center for Global Reproductive Health, University of California, San Francisco, CA, USAAbstract: Intrauterine
Maria Isabel Rodriguez, Darney, Philip D, Philip D Darney, Philip Darney, Rodriguez, Maria Isabel, null Rodriguez   +5 more
core   +1 more source

Satisfaction with the Levonorgestrel 19.5-mg Intrauterine Device Treatment for Heavy Menstrual Bleeding: A Pilot Study. [PDF]

Open Access J Contracept
Marco Viscola, Ana Claudia H Marcelino, Paula da Cunha Pereira, Ximena Espejo-Arce, Luis Bahamondes Department of Obstetrics and Gynaecology, University of Campinas (UNICAMP), Faculty of Medical Sciences, Campinas, SP, BrazilCorrespondence: Luis ...
Viscola M, Marcelino ACH, Pereira PDC, Espejo-Arce X, Bahamondes L.   +4 more
europepmc   +2 more sources

Pharmacodynamic surrogates of levonorgestrel activity.

, 2022
Pharmacodynamic surrogates of levonorgestrel activity.
Nazita Yousefieh (751094), Betsy C. Herold (9634748), Leila Cochon (12621924), Elizabeth Tolley (5945897), Andrea R. Thurman (5286005), Vivian Brache (200187), Melissa Peet (13933074), Urvi Parikh (346278), Jill L. Schwartz (11434312), Susan Ju (5940782), Louise A. Ouattara (12210068), Gustavo F. Doncel (339755), Raina N. Fichorova (7251227), David W. Erikson (13933077), Homaira Hanif (10885137), Meredith R. Clark (11434306), Terry Jacot (5940767), Mark A. Marzinke (9579575), Neelima Chandra (5465411)   +18 more
core   +1 more source

Seguridad y aceptabilidad del sistema intrauterino liberador de levonorgestrel 52 mg en mujeres con hemorragia uterina anormal en un centro de atención ambulatoria en Bogotá, Colombia, 2012-2016

Revista Colombiana de Obstetricia y Ginecología, 2020
Objetivo: describir la seguridad y aceptabilidad del uso del sistema intrauterino liberador de levonorgestrel de 52 mg en mujeres con hemorragia uterina anormal. Materiales y métodos: cohorte retrospectiva en la que se incluyeron mujeres de 18 años o más
Patricia Sandoval-Vivas
doaj   +1 more source

Changes of Body Mass Index and Lipid Profile in Injectable Depot Medroxyprogesterone Acetate and Levonorgestrel Implant Acceptors

Indonesian Journal of Obstetrics and Gynecology, 2014
Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone ...
Irwan Daido, Andi M Tahir, St Maisuri T Chalid   +2 more
doaj   +1 more source

A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive Implant

Pharmaceutics
Background: Levonorgestrel implant is a highly effective hormonal contraceptive, but its efficacy may be compromised when used with cytochrome enzyme inducers such as efavirenz. The primary aim of this study was to evaluate methods of mitigating the drug
Lilian W. Adeojo, Rena C. Patel, Nancy C. Sambol   +2 more
doaj   +1 more source

Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study

BMJ Open, 2019
Objectives To assess whether changes in patterns of combined oral contraceptive (COC) prescriptions to starters between 2008 and 2016 were in line with changes in national recommendations for use.Design Historical prospective cohort study.Setting The ...
Julie Ekman, Finn Egil Skjeldestad
doaj   +1 more source